Tag: arterial disease

• Maybe it will work on CMT..?

  

  It seems the new hope for VM202 as a CMT1a treatment is perhaps Hellxmith’s latest attempt to find a market for an experimental product that has not panned out as hoped.

  Dan Knauss

  July 27, 2020

  News, Research

  ALS, arterial disease, clinical trials, CMT1A, diabetes, gene therapy, genetics, Helixmith, HGF, Lyrica, paracrine signalling, plasmid, VM202